Min Cao

1.5k total citations · 1 hit paper
63 papers, 891 citations indexed

About

Min Cao is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Oncology. According to data from OpenAlex, Min Cao has authored 63 papers receiving a total of 891 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 21 papers in Epidemiology and 13 papers in Oncology. Recurrent topics in Min Cao's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (18 papers), Inflammatory Myopathies and Dermatomyositis (9 papers) and Occupational and environmental lung diseases (6 papers). Min Cao is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (18 papers), Inflammatory Myopathies and Dermatomyositis (9 papers) and Occupational and environmental lung diseases (6 papers). Min Cao collaborates with scholars based in China, United States and United Kingdom. Min Cao's co-authors include Jianfeng Xie, Guozheng Wang, Karl P. Fischer, Glen S. Kwon, D. Lorne Tyrrell, John Samuel, Winnie W. Wong, William R. Addison, Hourong Cai and Mei Huang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Min Cao

58 papers receiving 875 citations

Hit Papers

Immune dysregulation in sepsis: experiences, lessons and ... 2023 2026 2024 2025 2023 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Min Cao China 17 243 230 217 195 116 63 891
Wendy Neveu United States 11 393 1.6× 253 1.1× 101 0.5× 150 0.8× 106 0.9× 14 957
Antonios G.A. Kolios Switzerland 20 477 2.0× 191 0.8× 232 1.1× 69 0.4× 102 0.9× 57 1.2k
Richard Le Naour France 20 319 1.3× 324 1.4× 83 0.4× 256 1.3× 102 0.9× 45 1.1k
Marina Tuzova United States 15 407 1.7× 219 1.0× 177 0.8× 57 0.3× 82 0.7× 17 953
Stefania Nicola Italy 18 436 1.8× 228 1.0× 84 0.4× 140 0.7× 192 1.7× 58 1.0k
Belinda J. Thomas Australia 15 296 1.2× 319 1.4× 242 1.1× 270 1.4× 59 0.5× 20 1.0k
Nikolaos M. Nikolaidis United States 16 344 1.4× 171 0.7× 118 0.5× 191 1.0× 78 0.7× 20 829
Emiliano Marasco Italy 17 421 1.7× 222 1.0× 212 1.0× 41 0.2× 77 0.7× 35 881
Azzaq Belaaouaj France 14 354 1.5× 327 1.4× 137 0.6× 281 1.4× 130 1.1× 16 1.3k
Vidal Delgado‐Rizo Mexico 14 579 2.4× 284 1.2× 129 0.6× 96 0.5× 52 0.4× 28 930

Countries citing papers authored by Min Cao

Since Specialization
Citations

This map shows the geographic impact of Min Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Cao more than expected).

Fields of papers citing papers by Min Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Cao. The network helps show where Min Cao may publish in the future.

Co-authorship network of co-authors of Min Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Min Cao. A scholar is included among the top collaborators of Min Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Cao. Min Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Yanfei, Yue Gu, You Zhang, et al.. (2025). Head-to-head comparison of peptide-based and nanobody-based radiotracers in detecting PD-L1 expression in non-small cell lung cancer. European Journal of Nuclear Medicine and Molecular Imaging. 52(12). 4477–4486. 1 indexed citations
2.
Tian, Yaqiong, Xuan Zhou, Mi Tian, et al.. (2025). Nomogram model using serum Club cell secretory protein 16 to predict prognosis and acute exacerbation in patients with idiopathic pulmonary fibrosis. European journal of medical research. 30(1). 20–20.
4.
Liu, Chang, et al.. (2025). The predictive value of SOFA and APSIII scores for 28-day mortality risk in SIMI: a cohort study based on the MIMIC-IV database. Frontiers in Cellular and Infection Microbiology. 15. 1574625–1574625.
5.
Gui, Xianhua, Wang‐Zhong Li, Tingting Zhao, et al.. (2024). Pretreatment mortality risk prediction model in patients with polymyositis/dermatomyositis-associated interstitial lung disease. RMD Open. 10(2). e003850–e003850. 1 indexed citations
6.
7.
Liu, Qingxing, Fei Xie, Yanjiang Han, et al.. (2023). Radiosynthesis, preclinical evaluation and pilot clinical PET imaging study of a 18F-labeled tracer targeting fibroblast activation protein. Bioorganic Chemistry. 141. 106878–106878. 7 indexed citations
8.
Hou, Wei, et al.. (2023). Risk factors for postoperative sympathetic chain dysfunction following oblique lateral lumbar interbody fusion: a multivariate analysis. European Spine Journal. 32(7). 2319–2325. 2 indexed citations
9.
Cao, Min, Guozheng Wang, & Jianfeng Xie. (2023). Immune dysregulation in sepsis: experiences, lessons and perspectives. Cell Death Discovery. 9(1). 465–465. 89 indexed citations breakdown →
10.
Gui, Xianhua, Hui Ding, Tingting Zhao, et al.. (2022). Anti-Ro52 antibodies are associated with the prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease. Lara D. Veeken. 61(11). 4570–4578. 44 indexed citations
11.
Li, Fan, Yin Liu, Yi Zhuang, et al.. (2022). A Retrospective Analysis of Outcome in Melanoma Differentiation–Associated Gene 5–Related Interstitial Lung Disease Treated with Tofacitinib or Tacrolimus. The Journal of Rheumatology. 49(12). 1356–1364. 27 indexed citations
12.
Cao, Min, Qing Wang, Hang Yin, Yujie Fu, & Xiaojing Zhao. (2021). Short-term analysis of uniport video-assisted thoracoscopic surgery via the subxiphoid approach without chest tube drainage for anterior mediastinal tumors: a comparative retrospective study. Annals of Translational Medicine. 9(22). 1687–1687. 5 indexed citations
13.
Cao, Min, Huihui Liu, Yujun Dong, et al.. (2021). Mesenchymal stem cells alleviate idiopathic pneumonia syndrome by modulating T cell function through CCR2-CCL2 axis. Stem Cell Research & Therapy. 12(1). 378–378. 12 indexed citations
14.
Cao, Min, et al.. (2020). The advances of traditional Chinese medicine in the treatment of liver diseases in 2019. SHILAP Revista de lepidopterología. 6 indexed citations
16.
Liu, Yin, et al.. (2020). Correlation between serum bilirubin levels and the severity as well as the prognosis of idiopathic pulmonary fibrosis. Chronic Respiratory Disease. 17. 405200108–405200108. 1 indexed citations
17.
Gui, Xianhua, Xiaohua Qiu, Yaqiong Tian, et al.. (2020). Prognostic Value of Serum Osteopontin in Acute Exacerbation of Idiopathic Pulmonary Fibrosis. BioMed Research International. 2020(1). 3424208–3424208. 30 indexed citations
18.
Yang, Yang, et al.. (2018). A comprehensive analysis of the allergenicity and IgE epitopes of myosinogen allergens in Scylla paramamosain. Clinical & Experimental Allergy. 49(1). 108–119. 37 indexed citations
19.
Liu, Yin, et al.. (2016). Pulmonary infiltration with eosinophilia complicated with mucosa-associated lymphoid tissue lymphoma: A case report. Oncology Letters. 12(3). 1818–1820. 1 indexed citations
20.
Davoine, Francis, et al.. (2008). Virus-induced eosinophil mediator release requires antigen-presenting and CD4+ T cells. Journal of Allergy and Clinical Immunology. 122(1). 69–77.e2. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026